A detailed history of High Vista Strategies LLC transactions in Amgen Inc stock. As of the latest transaction made, High Vista Strategies LLC holds 10,101 shares of AMGN stock, worth $2.66 Million. This represents 1.27% of its overall portfolio holdings.

Number of Shares
10,101
Holding current value
$2.66 Million
% of portfolio
1.27%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$309.38 - $337.38 $3.13 Million - $3.41 Million
10,101 New
10,101 $3.25 Million
Q3 2019

Nov 14, 2019

SELL
$174.11 - $208.62 $487,508 - $584,136
-2,800 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$166.7 - $195.41 $466,759 - $547,148
2,800 New
2,800 $516,000
Q1 2018

May 15, 2018

SELL
$169.43 - $198.0 $355,803 - $415,800
-2,100 Closed
0 $0
Q4 2017

Feb 14, 2018

SELL
$168.79 - $188.59 $101,274 - $113,154
-600 Reduced 22.22%
2,100 $365,000
Q3 2017

Nov 14, 2017

BUY
$167.29 - $191.0 $451,683 - $515,700
2,700
2,700 $503,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track High Vista Strategies LLC Portfolio

Follow High Vista Strategies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Vista Strategies LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Vista Strategies LLC with notifications on news.